• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Angiotensin Receptor/Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor Use in Patients With a Left Ventricular Assist Device: A Propensity Score Matched Analysis.

作者信息

Rawlley Bharat, Sanchez Andres Cordova, Gupta Kartik, Ramm Matthew, Chaudhuri Debanik

机构信息

Department of Internal Medicine, State University of New York Upstate Medical University, Syracuse, New York.

Division of Cardiology, Department of Medicine, University of Vermont Medical Center, Burlington, Vermont.

出版信息

Am J Cardiol. 2024 Jan 15;211:180-182. doi: 10.1016/j.amjcard.2023.10.020. Epub 2023 Oct 20.

DOI:10.1016/j.amjcard.2023.10.020
PMID:37866448
Abstract
摘要

相似文献

1
Angiotensin Receptor/Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor Use in Patients With a Left Ventricular Assist Device: A Propensity Score Matched Analysis.血管紧张素受体/中性肽链内切酶抑制剂与血管紧张素转换酶抑制剂在左心室辅助装置患者中的应用：倾向评分匹配分析
Am J Cardiol. 2024 Jan 15;211:180-182. doi: 10.1016/j.amjcard.2023.10.020. Epub 2023 Oct 20.
2
Incidence, Predictors, and Outcomes Associated With Hypotensive Episodes Among Heart Failure Patients Receiving Sacubitril/Valsartan or Enalapril: The PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure).沙库巴曲缬沙坦或依那普利治疗心力衰竭患者中与低血压发作相关的发生率、预测因素和结局：PARADIGM-HF 试验（血管紧张素受体脑啡肽酶抑制剂与血管紧张素转换酶抑制剂前瞻性比较，以确定对心力衰竭全球死亡率和发病率的影响）。
Circ Heart Fail. 2018 Apr;11(4):e004745. doi: 10.1161/CIRCHEARTFAILURE.117.004745.
3
Sacubitril/Valsartan: The Newest Addition to the Toolbox for Guideline-Directed Medical Therapy of Heart Failure.沙库巴曲缬沙坦：心力衰竭指南导向药物治疗工具库中的最新药物。
Am J Med. 2017 Jun;130(6):635-639. doi: 10.1016/j.amjmed.2017.02.010. Epub 2017 Mar 9.
4
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.血管紧张素受体拮抗剂与中性内肽酶抑制剂联合使用
Circulation. 2016 Mar 15;133(11):1115-24. doi: 10.1161/CIRCULATIONAHA.115.018622.
5
A Review of New Pharmacologic Treatments for Patients With Chronic Heart Failure With Reduced Ejection Fraction.射血分数降低的慢性心力衰竭患者新药物治疗综述
J Clin Pharmacol. 2016 Aug;56(8):936-47. doi: 10.1002/jcph.677. Epub 2015 Dec 30.
6
Comparative Effectiveness of Sacubitril-Valsartan Versus ACE/ARB Therapy in Heart Failure With Reduced Ejection Fraction.沙库巴曲缬沙坦与 ACE/ARB 治疗射血分数降低的心力衰竭的疗效比较。
JACC Heart Fail. 2020 Jan;8(1):43-54. doi: 10.1016/j.jchf.2019.08.003. Epub 2019 Dec 11.
7
Angiotensin Receptor Neprilysin Inhibition Across Ejection Fraction and Acuity Spectra in Heart Failure.射血分数和心力衰竭严重程度范围内的血管紧张素受体脑啡肽酶抑制作用
JACC Heart Fail. 2024 Mar;12(3):583-587. doi: 10.1016/j.jchf.2023.11.021. Epub 2024 Jan 24.
8
Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.射血分数对沙库巴曲缬沙坦（LCZ696）治疗射血分数降低的心力衰竭的疗效及预后的影响：ARNI与ACEI对心力衰竭全球死亡率和发病率影响的前瞻性比较（PARADIGM-HF）试验
Circ Heart Fail. 2016 Mar;9(3):e002744. doi: 10.1161/CIRCHEARTFAILURE.115.002744.
9
Potential Uses of Sacubitril/Valsartan: Need for Data on Efficacy and Safety.沙库巴曲缬沙坦的潜在用途：对疗效和安全性数据的需求。
Am J Cardiovasc Drugs. 2019 Feb;19(1):1-10. doi: 10.1007/s40256-018-0306-z.
10
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial.血管紧张素受体-脑啡肽酶抑制剂对急性心肌梗死患者主要冠脉事件的影响：来自 PARADISE-MI 试验的见解。
Circulation. 2022 Dec 6;146(23):1749-1757. doi: 10.1161/CIRCULATIONAHA.122.060841. Epub 2022 Nov 2.

引用本文的文献

1
A Systematic Review and Meta-Analysis of an Angiotensin Receptor-Neprilysin Inhibitor in Patients Using a Durable Left Ventricular Assist Device.使用持久性左心室辅助装置的患者中血管紧张素受体-中性肽链内切酶抑制剂的系统评价和荟萃分析
J Clin Med. 2024 Dec 20;13(24):7789. doi: 10.3390/jcm13247789.